510(k) K220262
K220262 is an FDA 510(k) premarket notification submitted by Siemens Healthcare Diagnostics, Inc. for the device "Dimension EXL LOCI BRAHMS Procalcitonin (PCT)". The FDA issued a decision of Substantially Equivalent on Aug 26, 2022. The device falls under product code PRI (Procalcitonin Assay), a Class II device regulated under 21 CFR 866.3215. Siemens Healthcare Diagnostics, Inc. has 246 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 26, 2022
- Date Received
- Jan 31, 2022
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Procalcitonin Assay
- Device Class
- Class II
- Regulation Number
- 866.3215
- Review Panel
- MI
- Submission Type
- 510(k)
To aid in decision making on antibiotic therapy, including antibiotic initiation and discontinuation, for inpatients or patients in the Emergency Department, with suspected or confirmed lower respiratory tract infections (LRTI) defined as community-acquired pneumonia (CAP), acute bronchitis, and acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
Need the full FDA record for Siemens Healthcare Diagnostics, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.